Izotropic Corporation

Equities

IZO

CA46604F1099

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange 01:02:30 18/06/2024 am IST 5-day change 1st Jan Change
0.11 CAD 0.00% Intraday chart for Izotropic Corporation -8.33% +10.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Izotropic Raises $180,000 With First Tranche of Non-Brokered Private Placement MT
Izotropic Corporation announced that it expects to receive CAD 0.3 million in funding CI
Izotropic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
Izotropic Corporation Receives Response from U.S. FDA CI
Izotropic Corporation Provides an Update on its Regulatory Status with the U.S. Food and Drug Administration and Operational Activities CI
Izotropic Corporation Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023 CI
Izotropic Corporation Reports Earnings Results for the First Quarter Ended July 31, 2023 CI
Izotropic Corporation Confirms Fda Pre-Submission Meeting Date with U.S. Food and Drug Administration CI
Izotropic Corporation Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices CI
Izotropic Corporation announced that it has received CAD 0.710331 million in funding CI
Izotropic Corporation announced that it expects to receive CAD 0.5 million in funding CI
Izotropic Corporation Reports Earnings Results for the Full Year Ended April 30, 2023 CI
Izotropic Corporation Announces Resignation of John McGraw as Board of Directors CI
Izotropic Corporation Announces John McGraw Has Resigned as Chief Executive Officer CI
Izotropic Corporation Completes Sub Submission with Fda Regarding Clinical Study CI
Izotropic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023 CI
Izotropic Corporation Announces CFO Changes CI
Izotropic Corporation Announces Executive Changes CI
Izotropic Corporation Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022 CI
Izotropic Completes IzoView Development and Assembly, Prepares for Final Testing CI
Izotropic Corporation Appoints Alexander Tokman to Board of Director CI
Izotropic Corporation announced that it has received CAD 1 million in funding CI
Izotropic Corporation Reports Earnings Results for the First Quarter Ended July 31, 2022 CI
Izotropic Corporation Reports Earnings Results for the Full Year Ended April 30, 2022 CI
Izotropic Corporation Auditor Raises 'Going Concern' Doubt CI
Chart Izotropic Corporation
More charts
Izotropic Corporation is a Canada-based medical device company. The Company is commercializing IzoView, a computed tomography (CT) imaging system, which produces images of anatomy for non-invasive tissue characterization with the first application in breast imaging. The Company has not generated any revenue.
More about the company
  1. Stock Market
  2. Equities
  3. IZO Stock
  4. News Izotropic Corporation
  5. Izotropic Raises $180,000 With First Tranche of Non-Brokered Private Placement